Trade Five Prime Therapeutics, Inc. - FPRX CFD
Five Prime Therapeutics, Inc. live chart
Still looking for a broker you can trust?
Capital.com Group 400,000+
Traders
90,000+
Active clients monthly
$65,000,000+
Monthly investing volume
$29,000,000+
Try now Withdrawn each month
- Summary
- Historical Data
Trading Conditions
- Long position overnight fee
- -0.0225%
- Short position overnight fee
- -0.0219%
- Overnight fee time
- 21:00 (UTC)
- Min traded quantity
- 1
- Currency
- USD
- Margin
- 20%
- Stock exchange
- United States of America
- Commission on trade
- 0%
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 15, 2021 | 37.95 | 0.03 | 0.08% | 37.92 | 37.95 | 37.91 |
| Apr 14, 2021 | 37.93 | 0.04 | 0.11% | 37.89 | 37.93 | 37.89 |
| Apr 13, 2021 | 37.89 | 0.00 | 0.00% | 37.89 | 37.91 | 37.89 |
| Apr 12, 2021 | 37.88 | -0.02 | -0.05% | 37.90 | 37.90 | 37.87 |
| Apr 9, 2021 | 37.88 | 0.01 | 0.03% | 37.87 | 37.90 | 37.85 |
| Apr 8, 2021 | 37.85 | -0.03 | -0.08% | 37.88 | 37.89 | 37.84 |
| Apr 7, 2021 | 37.87 | 1.50 | 4.12% | 36.37 | 37.91 | 36.37 |
| Apr 6, 2021 | 37.91 | 0.05 | 0.13% | 37.86 | 37.92 | 37.86 |
| Apr 5, 2021 | 37.62 | -0.14 | -0.37% | 37.76 | 37.85 | 37.55 |
| Apr 1, 2021 | 37.76 | 0.08 | 0.21% | 37.68 | 37.76 | 37.65 |
| Mar 31, 2021 | 37.64 | -0.06 | -0.16% | 37.70 | 37.80 | 37.64 |
| Mar 30, 2021 | 37.68 | -0.02 | -0.05% | 37.70 | 37.72 | 37.67 |
| Mar 29, 2021 | 37.67 | -0.07 | -0.19% | 37.74 | 37.76 | 37.67 |
| Mar 26, 2021 | 37.82 | 0.10 | 0.27% | 37.72 | 37.84 | 37.67 |
| Mar 25, 2021 | 37.72 | 0.01 | 0.03% | 37.71 | 37.84 | 37.66 |
| Mar 24, 2021 | 37.67 | -0.03 | -0.08% | 37.70 | 37.79 | 37.66 |
| Mar 23, 2021 | 37.68 | -0.01 | -0.03% | 37.69 | 37.78 | 37.67 |
| Mar 22, 2021 | 37.71 | -0.02 | -0.05% | 37.73 | 37.81 | 37.65 |
| Mar 19, 2021 | 37.83 | 0.17 | 0.45% | 37.66 | 37.88 | 37.60 |
| Mar 18, 2021 | 37.61 | -0.18 | -0.48% | 37.79 | 37.81 | 37.60 |
Content 2
Content 2
Five Prime Therapeutics, Inc. Company profile
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of innovative protein therapeutics. The company''s product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, which is in Phase 3 clinical trials to treat patients with gastric or gastroesophageal junction and GEJ cancer; and FPA150, a CD8 T cell checkpoint inhibitor antibody that is in Phase 1a/1b clinical trial that targets B7-H4 in various cancers, as well as FPT155, a soluble CD80 fusion protein, which is in Phase 1a/1b clinical trial that enhances co-stimulation of T cells through CD28. Its product candidates also include Cabiralizumab, an antibody that inhibits colony stimulating factor-1 receptor that is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with Opdivo. The company''s BMS-986258, an anti-T cell immunoglobulin and mucin domain-3 antibody, which is in Phase 1/2 clinical trial as a single agent and in combination with Opdivo in patients with advanced malignant tumors. It has license and collaboration agreements with Bristol-Myers Squibb Company, GlaxoSmithKline LLC, INBRX 110 LP, UCB Pharma S.A., and Zai Lab (Shanghai) Co., Ltd.; and license agreements with Galaxy Biotech, LLC, BioWa, Inc. and Lonza Sales AG. The company was founded in 2001 and is headquartered in South San Francisco, California.| Industry: | Bio Therapeutic Drugs |
111 Oyster Point Blvd
Two Corporate Drive
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Walgreens share price: What next for Boots as parent halts sale?
Walgreen has postponed the sale of Boots due to turmoil in the markets. What next?
09:19, 29 June 2022
Laos teeters towards economic collapse as kip crumbles
Pre-Covid structural issues have been accelerated by global inflation pressures
04:44, 29 June 2022
Nifty 50 today: cautious signs ahead over slower economy, say analysts
Overall economic indicators are still weighing down NSE Nifty 50 Index today (India 50)
02:38, 29 June 2022
Daily crypto wrap: Hive on a roll as other altcoin prices slide
Low-profile digital token soars about 30%
22:11, 28 June 2022
Spirit Airlines stock up as bidding war develops with Frontier and JetBlue
Frontier Holdings and JetBlue bidding war ahead of shareholder vote send Spirit stock higher amid down market
21:42, 28 June 2022People Also Watch
US Tech 100
11,656.60 Price
| Long position overnight fee | -0.0093% |
| Short position overnight fee | 0.0008% |
| Overnight fee time | 21:00 (UTC) |
| Spread | 1.0 |
Trade now
Still looking for a broker you can trust?
Join the 400.000+ traders worldwide that chose to trade with Capital.com
